<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Alteration in Frequency and Function of CD4+CD25+ FOXP3+  Regulatory T cells in Patients with Immune Thrombocytopenic Purpura</title>
    <FirstPage>85</FirstPage>
    <LastPage>92</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nargess</FirstName>
        <LastName>Arandi</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Mirshafiey</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmood</FirstName>
        <LastName>Jeddi-Tehrani</LastName>
        <affiliation locale="en_US">Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Shaghaghi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiency, Pediatrics Center of Excellence, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bamdad</FirstName>
        <LastName>Sadeghi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiency, Pediatrics Center of Excellence, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Abolhassani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiency, Pediatrics Center of Excellence, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ramazan Ali</FirstName>
        <LastName>Sharifian</LastName>
        <affiliation locale="en_US">Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Saeid</FirstName>
        <LastName>Rahiminejad</LastName>
        <affiliation locale="en_US">Division of Pediatric Hematology Oncology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Asghar</FirstName>
        <LastName>Aghamohammadi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiency, Pediatrics Center of Excellence, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Immune thrombocytopenic&#xA0; purpura (ITP) is an autoimmune bleeding disorder characterized by production&#xA0; of auto-antibodies against platelet antigens. It is obvious that regulatory T cells (Tregs) have a major role in controlling immune homeostasis and preventing autoimmunity.
To investigate the frequency and functions of Tregs, twenty ITP patients and twenty age- and sex- matched healthy controls were recruited. The peripheral blood mononuclear cells were isolated and the proportion of Tregs was defined by flow cytometry method. The expression of immune-regulatory markers, cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and glucocorticoid induced tumor necrosis&#xA0; factor&#xA0; receptor&#xA0; (GITR)&#xA0; were&#xA0; also&#xA0; assessed by&#xA0; quantitative&#xA0; Real-time polymerase chain reaction TaqMan method. For evaluation of Treg function, Tregs were enriched and their ability to inhibit proliferation of T cells was measured and levels of immune-regulatory cytokines IL-10 and Transforming growth factor beta (TGF-&#x3B2;) were also measured.Results showed that the frequency of Tregs&#xA0; and&#xA0; the&#xA0; mean&#xA0; fluorescence&#xA0; intensity&#xA0; of&#xA0; forkhead&#xA0; box&#xA0; P3&#xA0; (FOXP3)&#xA0; protein&#xA0; significantly decreased in ITP patients compared to those in healthy controls. In addition, there was a significant reduction&#xA0; in relative expression of both&#xA0; CTLA-4 and GITR&#xA0; mRNA&#xA0; in ITP&#xA0; patients (p=0.02 and p=0.006, respectively). The suppressive function of Tregs also diminished in ITP patients compared to controls. Both&#xA0; IL-10 and TGF-&#x3B2;&#xA0; cytokines were produced&#xA0; in lower amounts &#xA0;in ITP&#xA0; patients than controls.
It&#xA0; could&#xA0; be&#xA0; concluded&#xA0; that&#xA0; alteration&#xA0; in&#xA0; Treg&#xA0; frequency and&#xA0; functional&#xA0; characteristics might&#xA0; be responsible for loss of self-tolerance and subsequently destructive immune responses observed in ITP patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/472</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/472/365</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Effects of Vitamin D on Allergen-Induced Expression of Interleukin-13 and Interleukin-17 in Cord Blood CD4+T Cells</title>
    <FirstPage>93</FirstPage>
    <LastPage>97</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hui</FirstName>
        <LastName>Zhong</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiao Jian</FirstName>
        <LastName>Zhou</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai, China</affiliation>
      </Author>
      <Author>
        <FirstName>Jian Gou</FirstName>
        <LastName>Hong</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Cytokine production&#xA0; in response to allergens may influence the development of atopy- predisposing immune responses, initializing the&#xA0; early programming of&#xA0; allergy and&#xA0; asthma. Vitamin D&#xA0; intake&#xA0; may be&#xA0; protective&#xA0; due&#xA0; to&#xA0; its&#xA0; immunoregulatory properties,&#xA0; that&#xA0; may contribute&#xA0; to&#xA0; influence the expression of&#xA0; the atopic phenotype&#xA0; initiated in early life. The objective of our study was to investigate the effects of 1,25-(OH)2D3 on allergen-stimulated expression of asthma related cytokines in cord blood T cells.
Cord blood samples were collected from the umblilical vein of 24 term deliveries during labor, CD4+T cells derived from cord blood mononuclear cells (CBMCs), were cultured for 72 hours with ovalbumin (OVA), &#x3B2;-lactoglobulin (&#x3B2;-LG), respectively, in presence or absence of 1,25-(OH)2D3&#xA0; to detect the levels of interleukin-13 (IL-13) and interleukin-17 (IL-17) in culture supernatants and the mRNA expressions in CD4+T cells.
After&#xA0; allergens&#xA0; stimulation,&#xA0; CD4+T&#xA0;&#xA0; cells&#xA0; showed&#xA0; an&#xA0; increase&#xA0; of&#xA0; IL-13&#xA0; and&#xA0; IL-17 production, while cultured in the presence of 1,25-(OH)2D3&#xA0; displayed a statistically significant down-regulation of allergen-induced expression of IL-13 and IL-17 in CD4+T cells.
These&#xA0; results indicated that&#xA0; allergens may induce changes in CD4+T&#xA0; cell function&#xA0; to increase inflammatory cytokine production. 1,25-(OH)2D3&#xA0; modulated the capacity of CD4+T cells in response to allergens, which might be protective for allergy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/471</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/471/366</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Vitamin E Supplementation, Lung Functions and Clinical Manifestations in Children with Moderate Asthma: A Randomized Double Blind Placebo- Controlled Trial</title>
    <FirstPage>98</FirstPage>
    <LastPage>103</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Ghaffari</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Molecular and Cellular Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Farid Hossiani</LastName>
        <affiliation locale="en_US">Department of Allergy and Clinical Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Khalilian</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Negin</FirstName>
        <LastName>Nahanmoghadam</LastName>
        <affiliation locale="en_US">Department of General Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ebrahim</FirstName>
        <LastName>Salehifar</LastName>
        <affiliation locale="en_US">Department of Pharmacology, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Houshang</FirstName>
        <LastName>Rafatpanah</LastName>
        <affiliation locale="en_US">Department of Immunology, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma is the most&#xA0; common&#xA0; chronic inflammatory disorder characterized by cough, wheezing and dyspnea in children. Nutrition&#xA0; is an important&#xA0; factor which influences on induction and exacerbation of asthma. There are controversies to use Vitamin E in asthmatic patients. The aim of this study was to evaluate the effect of vitamin E supplement in children with moderate asthma.
This is a randomized double blind placebo-controlled trial performed on children (age 2-17 years old) with moderate asthma (5-17 years old) from March 2010 to March 2012. Case group were treated with fluticasone and vitamin E (50mg/day) and control group received fluticasone plus placebo for 8 weeks.
Out of 300 cases, 240 cases completed the study. Female to male ratio was 0.84. Serum level of Vitamin E significantly increased after treatment in intervention group. FEV1 and FEV1/FVC ratio was ignificantly improved in case group compared to the control group.
It can be concluded that vitamin E supplement could improve clinical manifestations and pulmonary function test in children with moderate asthma.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/470</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/470/367</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Gastroesophageal Reflux Disease and Asthma in Pregnant Women with Dyspnea</title>
    <FirstPage>104</FirstPage>
    <LastPage>109</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Katayoon</FirstName>
        <LastName>Bidad</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Heidarnazhad</LastName>
        <affiliation locale="en_US">Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Giti</FirstName>
        <LastName>Shayestefar</LastName>
        <affiliation locale="en_US">Department of Obstetrics, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Heshmat</FirstName>
        <LastName>Moayeri</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Zendehdel</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma and&#xA0; gastroesophageal reflux disease (GERD)&#xA0; are two&#xA0; common&#xA0; problems&#xA0; in pregnancy and they affect pregnancy in several ways. In this study, we aimed to evaluate GERD and asthma in pregnant women who referred for prenatal care visits.
One-hundred&#xA0; and seventy three&#xA0; pregnant&#xA0; women with a complaint of&#xA0; dyspnea were included in the study. A questionnaire was filled and lung function tests were performed. All patients&#xA0; were visited by a respiratory specialist and&#xA0; questionnaires were evaluated by a gastroenterologist.
Out&#xA0; of the total number of women studied, 37% were diagnosed to have asthma and 36.4% were non-asthmatics. Twenty six percent of the pregnant women who had symptoms and signs of asthma with normal spirometry were classified as probable to have asthma. GERD was diagnosed in 80.9% of the pregnant women, but it was not significantly higher in asthmatic or probable asthmatic women compared to non-asthmatic ones. However, severity of GERD was significantly higher in asthmatic pregnant women compared to the others.
In conclusion, the prevalence of GERD&#xA0; was quite high in pregnant women, irrespective of the fact that they were asthmatic or non-asthmatic. Further studies evaluating women throughout pregnancy will inform us more about this relationship.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/469</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/469/368</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Immunological Parameters in Diabetic Patients: Are These Patients Immunodeficient?</title>
    <FirstPage>110</FirstPage>
    <LastPage>119</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zoleikha</FirstName>
        <LastName>Moazezi</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Ayatollah Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Hosseinian</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Ayatollah Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ensiyeh</FirstName>
        <LastName>Ahmad Moazam</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Ayatollah Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohamed Bagher</FirstName>
        <LastName>Eslami</LastName>
        <affiliation locale="en_US">Department of Pathobiology, Faculty of Health, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ezatollah</FirstName>
        <LastName>Mosavi</LastName>
        <affiliation locale="en_US">Department of Microbiology and Immunology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Haleh</FirstName>
        <LastName>Akhavan-Niaki</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Bijani</LastName>
        <affiliation locale="en_US">Non- Communicable Pediatrics Diseases Research Center, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nanette</FirstName>
        <LastName>Schloot</LastName>
        <affiliation locale="en_US">Department of Immunobiology, &#xA0;German Diabetes Research Center, Dusseldorf, Germany.</affiliation>
      </Author>
      <Author>
        <FirstName>Amrollah</FirstName>
        <LastName>Mostafazadeh</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">It has been widely thought that diabetic patients are prone to infections due to hyperglycemia induced immunodeficiency; the present study was designed to examine this opinion. In diabetic patients and normal control groups T-cell reactivity to hsp-60 molecule, tetanus toxoid recall antigen (TT) and phytohemagglutinin-A (PHA) mitogen were evaluated The number of circulating IFN-&#x3B3;, IL-10 and IL-13 cytokine producing cells stimulated with above antigens or mitogen as well as the serum levels of Th1/Th2 type cytokines were determined. Total serum immunoglobulins (IgG, IgA, IgM), C3, C4 and CH50 were also measured. Diabetic patients showed a positive circulating T-cell reactivity to human recombinant hsp60 However, this reactivity was significantly lower in comparison to control group (p&lt;0.001). All other examined factors were not significantly different between diabetic and normal subjects except for the number of IFN-&#x3B3; and IL-13 producing cells in response to PHA stimulation, which was higher in control gtroup (p=0.006, 0.018, respectively). The mean serum concentration of IgA in diabetic patients was 245.86 &#xB1; 115.05 mg/dl versus 192.96 &#xB1; 105.33 mg/dl in healthy control group (p&lt;0.018). We were not able to demonstrate any substantial mitigation in cellular arms of immune reaction to some prominent T-cell antigens and mitogens, as well as, in main parameters of humoral immunity of diabetic patients, thus, the common notion of believing that patients with diabetes suffering from immunodeficiency should be revised. It is much more appropriate that "altered immunity" is applied instead of "immunodeficiency" to explain the immunity condition in this group of patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/468</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/468/369</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Mannan-Binding Lectin Serum Levels in 593 Healthy Iranian Children and Adults</title>
    <FirstPage>120</FirstPage>
    <LastPage>124</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Zahedifard</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elahe</FirstName>
        <LastName>Rashidi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sedigheh</FirstName>
        <LastName>Shams</LastName>
        <affiliation locale="en_US">Department of Pathology, Children Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shiva</FirstName>
        <LastName>Saghafi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Fazlollahi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Talebzadeh</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Anoushirvan</FirstName>
        <LastName>Kazemnejad</LastName>
        <affiliation locale="en_US">Department of Bio; a&#xA0; Short&#xA0; Form-36&#xA0; health&#xA0; survey&#xA0; (SF-36)&#xA0; and&#xA0; Structured&#xA0; Clinical Interview Form for DSM-III-R Axis-II Disorders (SCID-II).
All&#xA0; SF-36&#xA0; questionnaire&#xA0; scores&#xA0; of&#xA0; asthmatic&#xA0; patients&#xA0; were&#xA0; significantly&#xA0; lower&#xA0; than the&#xA0;&#xA0; controls.&#xA0;&#xA0; There&#xA0;&#xA0; were&#xA0;&#xA0; statistical&#xA0;&#xA0; differences&#xA0;&#xA0; between&#xA0;&#xA0; the&#xA0;&#xA0; asthma&#xA0;&#xA0; severity&#xA0;&#xA0; and the&#xA0; mean&#xA0; scores&#xA0; of&#xA0; vitality&#xA0; and&#xA0; emotional&#xA0; role&#xA0; difficulties&#xA0; of&#xA0; HRQL&#x2019;s&#xA0; subdomains (p=0.03, p=0.014, respectively). There was a weak but statistically significant correlation between the scores of pain and emotional role difficulties, and forced expiratory volume in 1 second (FEV1) (r=0.27, p=0.007; r=0.24, p=0.01, respectively). When compared to healthy&#xA0; controls,&#xA0; patients&#xA0; with&#xA0; asthma&#xA0; had&#xA0; higher&#xA0; prevalence&#xA0; of&#xA0;&#xA0; PDs&#xA0;&#xA0; (p=0.0001). The&#xA0; most&#xA0; common&#xA0; PDs&#xA0; found&#xA0; in&#xA0; asthmatic&#xA0; patients&#xA0; were&#xA0; obsessive-compulsive&#xA0; and avoidant&#xA0;&#xA0; PDs.&#xA0;&#xA0; HRQL&#xA0;&#xA0; values&#xA0;&#xA0; of&#xA0;&#xA0; asthma&#xA0;&#xA0; patients&#xA0;&#xA0; with&#xA0;&#xA0; PDs&#xA0;&#xA0; were&#xA0;&#xA0; significantly lower&#xA0; than&#xA0; patients&#xA0; without&#xA0; PDs&#xA0; except&#xA0; for&#xA0; the&#xA0; physical&#xA0; functioning&#xA0; subscores&#xA0; on HRQL.
We&#xA0; conclude&#xA0; that&#xA0; patients&#xA0; with&#xA0; asthma&#xA0; have&#xA0; higher&#xA0; prevalence&#xA0; of&#xA0; PDs,&#xA0; which&#xA0; is associated with their poor quality of life. A psychiatric evaluation may be beneficial in patients with asthma if a concomitant PD is suspected.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/477</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/477/360</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Assessment of the Quality of Life in Patients with Bronchial Asthma, Before and After Yoga: a Randomised Trial</title>
    <FirstPage>55</FirstPage>
    <LastPage>60</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Candy</FirstName>
        <LastName>Sodhi</LastName>
        <affiliation locale="en_US">Department of Physiology, Christian Medical College and Hospital, Ludhiana, Punjab, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Sheena</FirstName>
        <LastName>Singh</LastName>
        <affiliation locale="en_US">Department of Physiology, Christian Medical College and Hospital, Ludhiana, Punjab, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Amit</FirstName>
        <LastName>Bery</LastName>
        <affiliation locale="en_US">Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Yoga which is used as an adjunct treatment for bronchial asthma is gaining popularity throughout the world. The objective of this study was to assess the effect of yoga on quality of life in patients with bronchial asthma. 120 non-smoking male and female patients of asthma in the age group of 17-50 years were randomized into two groups i.e. Group A (Yoga group) and Group B (control group). All patients remained on their prescribed medication, but Group A patients practiced yoga breathing exercises for 8 weeks. Asthma Quality of Life Questionnaire (AQLQ) and diary record was used to assess quality of life, number and severity of asthmatic attacks, and the dosage of the medication required at baseline and after 8 weeks. Group A subjects showed a statistically significant improvement in "symptoms", "activities" and "environmental" domains of AQLQ at 8 weeks (p&lt;0.01) and significant reduction in daily number and severity of attacks, and the dosage of medication required at 4 and 8 weeks (p&lt;0.01) compared to the baseline. Yoga breathing exercises used adjunctively with standard pharmacological treatment significantly improved quality of life in patients with bronchial asthma.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/476</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/476/361</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prenatal Diagnosis of Leukocyte Adhesion Deficiency Type-1 (Five Cases from Iran with Two New Mutations)</title>
    <FirstPage>61</FirstPage>
    <LastPage>65</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Behnaz</FirstName>
        <LastName>Esmaeili</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Ghadami</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Fazlollahi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shirin</FirstName>
        <LastName>Niroomanesh</LastName>
        <affiliation locale="en_US">Department of Prenatalogy, Zanan Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Lida</FirstName>
        <LastName>Atarod</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Chavoshzadeh</LastName>
        <affiliation locale="en_US">Pediatric Infection Research Center, Mofid Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zeinab</FirstName>
        <LastName>Moradi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Allergy and Clinical Immunology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Leukocyte adhesion deficiency type-1(LAD-1) is one of the autosomal recessive immunodeficiency diseases that results from mutation in integrin beta 2 (ITGB2) gene. The aim of this study was to investigate molecular prenatal diagnosis of LAD-1. Four pregnant women with five fetuses (one twin fetus) with clinical and laboratory diagnosis of LAD-1 in their previous children were studied. The chorionic villus sampling (CVS) was obtained when mothers were in 10-12th weeks of gestation.
Mutation analysis of ITGB2 gene for affected children revealed 3 misssense mutations (c.382G&gt;A,&#xA0;&#xA0; a&#xA0;&#xA0; novel&#xA0;&#xA0; mutation,&#xA0;&#xA0; c.2146G&gt;C,&#xA0;&#xA0; and&#xA0;&#xA0; c.715G&gt;A)&#xA0;&#xA0; and&#xA0;&#xA0; one&#xA0;&#xA0; splice&#xA0; site novel mutation (c.1877+2T&gt;C). All parents were heterozygous for these mutations. Consideration of affected gene regions for five CVS samples showed two homozygotes and one heterozygote for mutant allele and two homozygotes for normal allele. Interestingly, one&#xA0; of&#xA0; the&#xA0; twin&#xA0; fetuses&#xA0; was&#xA0; affected&#xA0; and&#xA0; another&#xA0; was&#xA0; normal.&#xA0; Briefly, two&#xA0; cases&#xA0; of CVS samples were affected and three cases of remained CVS samples were unaffected.
This is the first report of prenatal diagnosis of LAD-1 from Iran with two new mutations that can be used for genetic and prenatal diagnosis for all patients suspected to LAD1 and can be helpful to prevent the birth of affected children with LAD-1.
This&#xA0; abstract&#xA0; was presented&#xA0; in&#xA0; the&#xA0; Second&#xA0; International&#xA0; Congress&#xA0; of&#xA0; Immunology, Asthma and Allergy, Tehran, Iran 2013.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/475</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/475/362</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Disseminated Aspergillosis as the Herald Manifestation of Chronic Granulomatous Disease in an Adult Patient</title>
    <FirstPage>66</FirstPage>
    <LastPage>70</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ilad</FirstName>
        <LastName>Alavi Darazam</LastName>
        <affiliation locale="en_US">National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Akhavan Zanjani</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Davood</FirstName>
        <LastName>Sanaee</LastName>
        <affiliation locale="en_US">National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Payam</FirstName>
        <LastName>Tabarsi</LastName>
        <affiliation locale="en_US">National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Alavi Moghaddam</LastName>
        <affiliation locale="en_US">National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Davood</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Chronic granulomatous disease is an inherited defect in intracellular killing of ingested microorganisms characterized by recurrent life threatening bacterial and fungal infections including invasive aspergillosis in early childhood.
We report&#xA0; a&#xA0; disseminated aspergillosis as&#xA0; the&#xA0; representative&#xA0; of&#xA0; adult&#xA0; onset&#xA0; chronic granulomatous disease without previous infection, with dramatic response to combination of antifungal and interferon therapy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/474</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/474/363</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Abortion in Iranian Legal System</title>
    <FirstPage>71</FirstPage>
    <LastPage>84</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Abbasi</LastName>
        <affiliation locale="en_US">Department of Medical Ethics, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ehsan</FirstName>
        <LastName>Shamsi Gooshki</LastName>
        <affiliation locale="en_US">Department of Medical Ethics, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Allahbedashti</LastName>
        <affiliation locale="en_US">Department of Medical Ethics, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Abortion traditionally means miscarriage and is still known as a problem, which societies have been trying to reduce its rate by using legal means. Despite the fact that&#xA0; pregnant women and fetuses have been historically supported;&#xA0; abortion&#xA0; was firstly criminalized in 1926 in Iran, 20 years after establishment of modern legal system.
During next 53 years this situation changed dramatically, thus in 1979, the time of Islamic Revolution, aborting fetuses up to 12 weeks of conception and therapeutic abortion (TA) during the&#xA0; entire period&#xA0; of&#xA0; pregnancy were legitimated, based on&#xA0; regulations that&#xA0; used medical justifications. After&#xA0; 1979 the&#xA0; situation&#xA0; changed&#xA0; into&#xA0; a&#xA0; totally conservative and restrictive approach and new Islamic concepts as &#x201C;Blood Money&#x201D; and &#x201C;Ensoulment&#x201D; entered the legal debates around abortion. During next 33 yea